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Abstract  23 
The wide variety of infant formula available on the market can be confusing for parents and 24 
physicians. We aimed to determine associations between predominant type of formula used 25 
from birth to 4 months and parental and child characteristics and type of physician consulted; 26 
then to describe relations between type of formula used and growth. Our analyses included 27 
1,349 infants from the EDEN mother-child cohort. Infant’s feeding mode and type of formula 28 
used were assessed at 4 months by maternal self-report. Infant’s weight and height from birth 29 
to 4 months, measured in routine follow-up were documented by health professionals in the 30 
infant’s personal health record. Anthropometric z-scores were calculated by using World 31 
Health Organization growth standards. Multinomial logistic regression was used to identify 32 
factors associated with type of formula predominantly used; relations with growth were 33 
analyzed by linear regressions. Partially hydrolyzed formulas were more likely to be used by 34 
primiparous women (p<0.001), those breastfeeding longer (p<0.001) and for infants with 35 
family history of allergies (p=0.002). Thickened formulas were more often used by mothers 36 
returning to employment in the first 4 months (p=0.05) and breastfeeding shortly (p<0.001). 37 
No significant relation was found between infant growth and type of formula (p>0.20). 38 
Infants breastfed shorter showed higher weight-for-age (p<0.001) and length-for-age 39 
(p=0.001) z-scores changes between birth and 4 months. The use of a specific type of infant 40 
formula seems to be mainly related to parental characteristics. Infant’s growth in the first 4 41 
months is related to other factors than to type of formula used. 42 
 43 
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Introduction  47 
 The benefits of breastfeeding on child health are well described in the literature (Van 48 
Rossum et al. 2001; Ip et al. 2007). The World Health Organization (WHO) and most of the 49 
international pediatric societies promote breastfeeding as optimal infant nutrition and 50 
recommend exclusive breastfeeding until 6 months (Boland 2005; Gartner et al. 2005; 51 
Agostoni et al. 2009). Despite these recommendations, many parents use infant formula 52 
before 6 months. The wide range of formulas available can be confusing and overwhelming 53 
for parents and physicians. Formula companies target physicians with advertising campaigns, 54 
advocating functional and beneficial effects of their products for infant health. Thickening 55 
agents, prebiotic, probiotics are added in some infant formulas. Prebiotics might have the 56 
potential to increase the total number of bifidobacteria present in the gut, and to soften stools 57 
(Boehm & Moro 2008; Sherman et al. 2009); and probiotics might play a role in preventing 58 
childhood diseases, especially diarrhea (Moreau 2001). Their effects on infant growth are not 59 
well known.  60 
 Several studies have been conducted to describe determinants of infant feeding mode 61 
(Butler et al. 2004; Lanting et al. 2005; Bolling et al. 2007; Grjibovski et al. 2008; 62 
Kristiansen et al. 2010) and their effects on child growth (Kramer et al. 2007; 63 
Griffiths et al. 2009). However, determinants of use of a specific formula compared to others 64 
are poorly described in the literature and very few studies (Koletzko et al. 2009) conducted on 65 
samples of significant size assess and compare their specific impact on child growth.  66 
 The prevalence of overweight children is rising and there is a strong evidence for an 67 
association between rapid weight gain in infancy and later obesity (Stettler 2007). Early 68 
feeding, especially milk feeding has been identified as important factor. Studies relating milk 69 
feeding to growth pattern often compare breastfed to formula-fed infants without 70 
distinguishing the different types of formulas. Some formulas may be given specifically to 71 
fast or slow grower infants and the influence of a specific formula on infant growth may 72 
depend on the characteristics of this formula. Before considering formula-fed infants as a 73 
single group we aimed to determine the associations between type of formula used and 74 
parental, child and physicians characteristics; and to describe their relations with infant 75 
growth from birth to 4 months. 76 
77 
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Materials and Methods 78 
Study design  79 
The EDEN mother-child cohort (study of pre- and early postnatal determinants of child 80 
health and development) recruited 2,002 pregnant women aged 18-45 years who presented 81 
before 24 weeks of gestation for prenatal care at the obstetrics and gynaecology department of 82 
Nancy and Poitiers University Hospitals. Enrolment started in February 2003 in Poitiers and 83 
September 2003 in Nancy; it lasted 27 months in each center. Exclusion criteria were multiple 84 
pregnancies, history of diabetes, illiteracy, moving outside the region planned in the next 85 
three years. The study received approval from the ethics committee (CCPPRB) of Kremlin-86 
Bicêtre. Files have been declared to the ‘National Committee for Processed Data and 87 
Freedom’ (CNIL). Written consent was obtained from mothers at enrolment, for fathers 88 
between mother’s enrolment and delivery and for infants after delivery. 89 
Data collection 90 
 At 24-28 weeks of gestation, mothers had a clinical examination performed by research 91 
midwives assistants, where their height was measured, using wall Seca 206 stadiometer 92 
(Hamburg, Germany) to the nearest 0.2 cm. Maternal education and pre-pregnancy weight, 93 
family income during pregnancy and family history of allergies were obtained by 94 
interviewing the mother. Paternal weight and height were measured with the same procedure 95 
at some point between mother’s inclusion and delivery. 96 
 Data were collected from obstetrical and pediatric records on parity, gestational age at 97 
delivery, birthweight (measured with electronic Seca scales, Seca 737 in Nancy and Seca 335 98 
in Poitiers; Hamburg, Germany), birth length (measured with a wooden somatometer; Testut, 99 
Béthune, France) and infant feeding at maternity discharge. 100 
 At 4 months, mothers completed questionnaires on which they reported infant’s weight and 101 
length measured every month since birth in routine follow-up and documented by health 102 
professionals in the infant’s personal health record (kept by the mother). Data on mothers’ 103 
return to employment in the first 4 months, type of physician consulted for the infant, feeding 104 
practices and infant health (diarrhea, regurgitations, colics) were also collected. Mothers 105 
reported in the 4-month questionnaire, if any, the different formula consumed by their infant 106 
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and the duration of consumption of each: less than a week / between 1 week and 1 month / 107 
more than 1 month but less than 4 months / since birth. 108 
Generated variables 109 
 In order to classify infants, because of frequent formula changes in the first 4 months in 110 
our sample, we estimated from the information collected the total duration of exposure to 111 
each type of formula. Infants were included into a specific predominant formula category if 112 
the total duration of exposure to that formula was higher than the total exposure to any other 113 
formula. Our study focused on regular, partially hydrolyzed, thickened (but not enriched in 114 
pre- or probiotics) and enriched in pre-or probiotics (thickened or not) formulas as these four 115 
types were the most consumed in our sample (Figure 1). We created a class ‘others’ with 116 
infants who were equally exposed to different formulas, or who had predominantly consumed 117 
formulas such as extensively hydrolyzed protein formula but were too few to constitute a 118 
class of the variable of interest. 119 
 Duration of exclusive breastfeeding (only breast-milk as milk feeds) from hospital 120 
discharge to 4 months was calculated using the information recorded by midwives at 121 
discharge and self-reported maternal feeding practices in the 4-month questionnaire for 122 
infants who received both breast- and formula-milk during their first 4 months of life. 123 
 Since children’s measurements were not collected at the same time point, we predicted 124 
individual infant weight and length at 4 months using non linear mixed effects models. 125 
Among the main parametric growth models (Hauspie 1989), Jenss Model (y= a+b×age–exp(c 126 
+ d×age)) best fitted our weight and length growth data from birth to one year of age, 127 
according to AIC fit parameter and residuals distribution over time. The model with a random 128 
effect on every parameter allowed to have individual equations of the weight (height resp.) 129 
growth trajectories by computing each of the four equation's parameters as the fixed-effect 130 
coefficient plus the random-effect term (Pinheiro & Bates 2000). Using the individual 131 
equations, we calculated predicted weight and length at four months for all the subjects. All 132 
available infant weight and height from birth to the 1-year clinical examination were used in 133 
growth modeling. Median and interquartile range of the number of measurements (for weight 134 
as well as for height) were 10 [7-12]. There was a median of 4 measurements for the 0-4 135 
month’s period, 3 for the 4-8 month’s period and 3 after 8 months. Among infants with at 136 
least one measurement during the first year, 100 % had at least one measurement of weight 137 
before 4 months, 81.9 % between 4 and 8 months and 87.2 % after 8 months (99.8 %, 81.6 % 138 
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and 87.4 % for height respectively). Finally, for the statistical analyses of associations, infants 139 
with fewer than 4 measurements in the first year were excluded since their growth trajectory 140 
could be shrunk toward the mean growth trajectory.  141 
 In order to facilitate comparisons of our data with other international studies, we used these 142 
predicted values to obtain weight-for-age (WFA), length-for-age (LFA) and weight-for-length 143 
(WFL) z-scores at birth and 4 months, according to WHO’s growth reference data (WHO 144 
Multicentre Growth Reference Study Group 2006). The different z-scores were then used in 145 
the statistical analysis to study relationships between infant growth and breast and infant 146 
formula feeding. 147 
 Parental body mass indexes (BMI) were computed as the reported pre-pregnancy weight 148 
(kg) / measured height squared (m
2
) for the mother and the measured weight (kg) / measured 149 
height squared (m²) for the father. When measurements were unavailable from the father, 150 
reported weight by the father (14.9%) was used, and reported height by the father (13.9%) or 151 
by the mother (7.6%) was used. Underweight was defined as a BMI (kg/m²) <18.5, normal 152 
weight as a BMI of 18.5-<25, overweight as a BMI of 25-<30 and obesity as a BMI ≥30. 153 
Because of small number of underweight fathers in the EDEN cohort (n=19; 1.0%), we 154 
grouped together fathers in the underweight and normal BMI categories. Parental heights 155 
were divided into quintiles.  156 
 To handle missing data, we proceeded as following: when percentage of missing value was 157 
lower than 5%, we imputed the modal class value (all except sex, EBF duration, gestational 158 
age, birthweight, paternal height and BMI) and when percentage of missing values was higher 159 
than 5%, they were grouped into a separate category (paternal height).  160 
Study sample  161 
 Of the 2,002 recruited women, 96 were excluded because they left the study before or at 162 
the time of delivery for personal reasons, 4 because of intra-uterine death, and 3 because they 163 
delivered outside the study hospitals. Data on birthweight were available for 1,899 newborns. 164 
We excluded 232 infants because the 4-month questionnaire was unavailable. When 165 
compared to the included mothers, the excluded mothers were less educated (29.7% vs. 166 
55.4% had a university degree, p<0.001) and less often born in France (80.6% vs. 90.4%, 167 
p<0.001). The excluded infants had a gestational age slightly higher than that of included 168 
infants (39.02 vs. 39.29, p=0.05). There were no statistical difference on infants’ sex (p=0.08) 169 
and birthweight (p=0.15). For the analyses, we selected infants who received formula at least 170 
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one week during the first 4 months and who had information about type of formula used 171 
(missing(n=27)). Analyses on formula-fed infants were therefore based on 1,354 infants. 172 
 To perform the analyses on post-natal growth, we selected a sub-sample of 1,239 infants 173 
with growth data from birth to 4 months. The 115 pairs excluded at this stage differed from 174 
the others by maternal education (University degree: 41.7% vs. 54.1%, p=0.02), birthweight 175 
(2,710 g vs. 3,319 g, p<0.001) and gestational age (37 weeks of amenorrhea vs. 39, p<0.001). 176 
Statistical analysis 177 
 Comparisons of means and proportions by formula group were performed by ANOVA or 178 
chi-square respectively (results not shown). Associations between type of formula (dependent 179 
variable) and covariates related to parental, child and health professional characteristics were 180 
measured by adjusted odds ratios estimated by multinomial logistic regression. 181 
 Relation between growth and type of formula were analyzed by multiple linear regressions. 182 
The dependent variable was the change in z-score between birth and 4 months (Δ z-score), 183 
which was the difference of z-scores between birth and 4 months. The models comprised type 184 
of formula, confounding variables that were significantly related to both growth and type of 185 
formula (center, education, family income, mother’s return to employment, EBF duration and 186 
type of physician consulted), variables highly related to growth (parental heights and BMIs, 187 
infant’ sex and gestational age), and variables related to type of formula used that might 188 
influence growth (occurrence of diarrhea and regurgitations). We also adjusted for the average 189 
z-score between 0 and 4 months to consider changes relative to the mean weight or height 190 
values. 191 
 Analyses were performed with SAS software (version 9.2; SAS Institute, NC, USA). A p-192 
value ≤0.05 was considered to indicate statistical significance for all the analyses. 193 
Results  194 
Description of formula-fed infants  195 
 Mothers were on average 29.5 years old and approximately 48% of them were primipara 196 
(Table 1). More than half of mothers had a university degree and for 91.4% of the families, 197 
both parents were born in France. The mean birthweight was 3,267 g and 5.8% of the infants 198 
were born preterm. The mean exclusive breastfeeding duration was 0.9 month. The rate of any 199 
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breastfeeding was 68.1% at maternity and 21.7% at 4 months. One third of the infants were 200 
predominantly exposed to regular formula (Figure 1). For 39 % of the infants, type of formula 201 
used never changed in the first 4 months, while about 26 % had their formula-milk changed 202 
twice or more. In infants who received different formulas in the first 4 months, the 203 
predominant formula was used 83 % of the time on average for those whose formula changed 204 
once and 77 % of the time for those whose formulas changed twice or more. 205 
 In the sub-sample with available data on growth (n=1,239), 1.3% of infants had a WFA z-206 
score > 2 standard deviation at birth and 0.3% at 4 months. The mean z-scores at different 207 
ages and by type of formula are presented in (Table 2). 208 
Determinants of infant formulas’ use 209 
 Partially hydrolyzed formulas were twice as likely to be used by the most educated 210 
mothers compared to regular formulas, but there was no statistical significant difference for 211 
the global comparison of the different formulas to regular formulas according to education 212 
level (Table 3). Partially hydrolyzed formulas were less likely to be used by multiparous 213 
mothers. Thickened formulas were more often used by mothers returning to employment in 214 
the first 4 months. Partially hydrolyzed and thickened formulas were more likely to be given 215 
to infants with family history of allergies than regular formula. Longer period exclusive 216 
breastfeeding was positively related to use of partially hydrolyzed formulas but negatively 217 
with thickened. Thickened formulas were more likely consumed by infants having 218 
regurgitations in the first 4 months. There was no significant association between family 219 
income or parent’s country of birth and type of formula (all p>0.19). 220 
 The use of formulas, even the enriched pre- or probiotic formulas, was associated neither 221 
with infant characteristics nor with occurrence of diarrhea in the first 4 months. Infants 222 
consuming other formulas than regular tended to consult more specialists (p=0.10).  223 
Relation with infant growth 224 
 No significant relation was found between weight and length growth and type of formula 225 
consumed predominantly during the first 4 months (Table 4) after adjustment on parental and 226 
child characteristics. Nonetheless, infants using partially hydrolyzed formula tended to have a 227 
lower WFL z-score change than those consuming regular. Infants that were shorter breastfed 228 
showed significant higher WFA and LFA z-scores changes but not WFL z-score.  229 
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 WFA z-score change of infants of obese mothers was significantly lower than that of 230 
infants whom mothers had a normal BMI; there was no association between maternal BMI 231 
and WFL z-score change. While paternal BMI was associated with infant weight gain 232 
regardless of BMI category, only paternal obesity seemed to be related to infants’ WFL z-233 
score. There was no significant interaction between exclusive breastfeeding period or type of 234 
formula used on the one hand and gestational age, maternal education, parental heights or 235 
BMIs on the other hand on infant growth (all p>0.10).  236 
 In a sensitivity analysis, we ran the same models, excluding premature infants 237 
(n=35, 2.82%) and the results did not change (data not shown). To determine the effects of 238 
imputations on our results, we ran the same models, without infants with missing values 239 
(n=88, 5.5 %) and the results remained similar to those presented above (data not tabulated). 240 
Discussion 241 
 Many studies have been conducted on determinants of feeding practices especially 242 
breastfeeding (Scott et al. 2006; Bonet et al. 2008; Grjibovski et al. 2008; 243 
Meedya et al. 2010), and impact of feeding on child growth (Agostoni et al. 1999; 244 
Harder et al. 2005) but as far as we are aware, ours is the first to examine relationships 245 
between type of formula used during the first months of life and characteristics related to 246 
parents, infants and type of physician consulted, including their associations with infant’s 247 
growth. We found that types of formula most frequently used in our cohort were related to 248 
parity, mother’s return to employment, family history of allergy, exclusive breastfeeding 249 
duration and infant’s regurgitations, to infants’ characteristics at birth to a lesser extent but 250 
not significantly to family income and parents’ country of birth. We did not found any 251 
significant association between types of formula most frequently used in the first 4 months 252 
and infant growth during the same period. 253 
 The prospective nature of the EDEN study allowed us to collect precisely the types of 254 
formula used and the variety of information collected led us to examine factors determining 255 
their use among mothers who did not want or could not exclusively breastfeed. However, 256 
because information about infant formulas prescription by physicians was not collected, we 257 
could not determine whether their use was due to physician's advice or to mothers’ personal 258 
decision. As changes in infant formula are quite frequent between birth and 4 months, we 259 
categorized children according to their predominant formula used. We acknowledge that this 260 
categorization does not take account of the reason for choice or for possible formula change 261 
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and may have weakened the relations, in particular with growth. Additional analyses were 262 
therefore performed to assess whether association between type of formula and growth was 263 
different in infants who received only the specific formula over the period or in those who 264 
changed formula and received it only as the predominant formula. Occurrence of formula 265 
changes in the first 4 months was not significantly related to growth (p-values: 0.30 for 266 
weight-for-age, 0.06 for length-for-age and 0.73 for weight-for-length z-score change).  There 267 
were no significant interactions between change in formula and type of predominant formula 268 
in relation to growth (p-value for the interactions: 0.32 for weight-for-age, 0.10 for length-for-269 
age and 0.62 for weight-for-length z-score change). Thus, we believe that our categorization 270 
do not mask any real associations with growth.  271 
 Our study population is not representative of the general population. Compared to the 272 
national perinatal survey carried out on 14,482 women who delivered in France in 2003 273 
(Blondel et al. 2006), women included in the EDEN study were more educated and more 274 
often employed. However, infants’ growth in the study fits well with the normal range of the 275 
WHO growth curves (WHO Multicentre Growth Reference Study Group 2006) (data not 276 
shown) and we believe that the relationships observed are applicable to a general population 277 
of infants born in France from middle class parents. However, we lacked power to detect 278 
associations related to low socioeconomic situations, which may explain that we do not find 279 
any association between income levels and type of formula.  280 
 Several studies have shown that primiparous mothers breastfed more than multiparous 281 
mothers at hospital discharge (Crost & Kaminski 1998; Bonet et al. 2008), and that 282 
breastfeeding duration was positively associated with being multiparous (Bolling et al. 2007). 283 
Our study goes further, analyzing associations between type of formula used and parity, and 284 
showing that multiparous (3 or more deliveries) use more often regular formula than others. 285 
Even if global family income was not related to type of formula, the previous associations 286 
may be related to family income available per child, as regular formulas are often considered 287 
as the cheapest on the French market. As already observed with breastfeeding 288 
(Butler et al. 2004), mothers’ experience with their first child has probably an effect on their 289 
practices with the following children.  290 
 Most of the pediatric societies recommend, in case of family history of allergy and after 291 
breastfeeding cessation, a partially hydrolyzed formula (Høst et al. 1999; Committee on 292 
Nutrition of American Academy of Pediatrics 2000; Chouraqui et al. 2008a). In our study, 293 
consumption of partially hydrolyzed formulas was positively associated with family history of 294 
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allergies and exclusive breastfeeding duration, which is consistent with current 295 
recommendations. 296 
 It has been demonstrated that mothers giving formula to their infant returned to 297 
employment during the first 4 months after delivery (Stewart-Knox et al. 2003; Bolling et al. 298 
2007; Hawkins et al. 2007). It has also been shown that adding cereals to babies’ bottle to 299 
extend sleep bouts although not recommended, is part of maternal beliefs that can have an 300 
influence on feeding practices (Kannan et al. 1999; Kavanagh et al. 2010). We found a 301 
positive association between consumption of thickened formula and mother’s return to 302 
employment, suggesting that mothers may use thickened formula to promote sleep or ‘settle’ 303 
their infant. 304 
 Research documenting the efficacy of pre- or probiotics is still emerging; the benefits of 305 
adding them in infant formulas remain unclear (Szajewska et al. 2006; 306 
Douglas & Sanders 2008; Thomas & Greer 2010; Braegger et al. 2011). Contrary to other 307 
studies (Guarino et al. 1997; Szajewska & Mrukowicz 2001), we found no significant 308 
association between using enriched pre- or probiotic formulas and digestive disorders, 309 
especially the occurrence of diarrhea in the first 4 months. However, because of our sample 310 
size, we had to group together all infants using pre- or probiotics (or both) regardless of the 311 
type of oligosaccharides or strains included in the formula. That could explain part of this lack 312 
of association as the effects of probiotics for instance are strains dependant (Szajewska & 313 
Mrukowicz 2005; Canani et al. 2007; Braegger et al. 2011). Our results showed an 314 
association between consuming enriched pre- or probiotic formulas and occurrence of 315 
regurgitations, probably because we grouped together enriched in pre- or probiotics formulas 316 
and those both thickened and enriched.  317 
 Growth parameters were not related to type of formula after adjustment for parental and 318 
child characteristics in our analysis. Formula-fed infants are known to grow more rapidly than 319 
breastfed infants from about the third month in the first year of life (Dewey et al. 1995; 320 
Kramer et al. 2004). We showed that infants who were breastfed longer had significant lower 321 
WFA and LFA z-scores changes between 0 and 4 months but not for WFL z-score suggesting 322 
a slower but, harmonious growth in weight and length. Evidences indicates long term effects 323 
of feeding practices and of rapid weight gain during early infancy on infant growth patterns 324 
(Ong et al. 2000) but mechanisms underlying the differences between the patterns are not 325 
well known. Regarding the use of infant formula, one might ask the question of the effect of 326 
the composition of infant formulas on early growth. A clinical trial showed that lower protein 327 
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content in infant formula was associated with a lower weight gain during the first 2 years of 328 
life (Koletzko et al. 2009). We could not explore the relation between consumption of lower 329 
protein formula and growth in our analyses because these formulas have been recently 330 
introduced in France and very few infants have used them in our sample (n=42, Figure 1). 331 
Furthermore, the basic composition of formulas consumed in the EDEN study was almost 332 
homogeneous in terms of protein and energy contents, according to European regulations.  333 
 Effects of pre- or probiotics and of thickened formulas on infant growth are poorly 334 
documented. As most of the studies on the topic (Chouraqui et al. 2008b; 335 
Braegger et al 2011), we found that adding pre- or probiotics in infant formulas was not 336 
related to infant’s weight and length gain. We found a negative relation between type of 337 
physician consulted and WFL z-score change. Infants consulting pediatricians are more likely 338 
to be the sickest which probably explains their significantly lower WFL z-score change 339 
during the study period. However, we acknowledge that our analyses cannot attribute cause 340 
and effect.  341 
 In our study, maternal obesity was related to a significantly slower weight growth while 342 
paternal BMI was related to a faster infant weight and length growth and parental heights to a 343 
faster infant length growth. As we discussed previously (Mok et al. 2008; 344 
Regnault et al. 2010), both genetic and pre- and postnatal environmental factors are known to 345 
contribute to parental influence on infant growth. Our analysis showed that these parent-infant 346 
relationships, and especially those with parental BMI, are observed whatever the infant 347 
feeding mode, including the type of formula used. 348 
Conclusion 349 
 The range of infant formulas is quite varied and factors related to the infant, such as 350 
prematurity, digestive disorders and allergy, may influence the use. Besides these factors, our 351 
results pointed out relationships with other factors related to family, such as parity, maternal 352 
education level and employment status, that should be taken into account when describing 353 
relationships between the use of infant formulas and growth. In our study, after adjusting for 354 
these factors, the type of formula used was not related to infant growth nor to other health 355 
aspects such as diarrhea. In contrast, exclusive breastfeeding duration seems to affect 356 
significantly infant growth between birth and 4 months after taking into account family and 357 
child characteristics. 358 
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Key messages 359 
 The use of infant formulas (partially hydrolyzed, thickened, enriched in pre- or probiotic 360 
and others) in the first four months of life seems to be essentially related to maternal return 361 
to employment, parity and parental history of allergies. 362 
 Infant growth was not related to type of formula predominantly used in our study. 363 
 Infants who were breastfed shorter showed higher growth between birth and 4 months. 364 
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Figure 1: Types of formula used predominantly or not in the EDEN study. Includes 1354 516 
infants exclusively formula-fed or not in the first 4 months of life. In infants who were in the 517 
regular category, regular formulas were used 95 % of the time on average. Similarly, in the 518 
other groups, pre- or probiotics, thickened and partially hydrolyzed formulas were used 519 
respectively 89, 85 and 95 % of the time on average. *Regular, pre- or probiotic, thickened 520 
and partially hydrolyzed formulas: successive or concomitant use. 521 
522 
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 523 
TABLE 1: Characteristics of parents and offspring (n=1354).  
Variable  n 
Mean ± SD                       
or % yes 
Parental characteristics     
Education (% university degree) 1332  53.0 % 
Monthly family income ≤3,000 € 1346  72.1 % 
Primiparous  1351  48.0 % 
Mother lives with a partner 1335  95.3 % 
Mother returned to employment in the first 4 months 1341  45.7 % 
Family history of allergy 1346  50.5 % 
Both parents born in France 1354  91.4 % 
Maternal age at delivery (yrs)  1354  29.5 ± 4.8 
Maternal height (cm) 1334  163.4 ± 6.1 
Paternal height (cm) 1344  176.8 ± 6.4 
Maternal prepregnancy BMI < 25 kg/m² 1324  71.2 % 
Paternal BMI < 25 kg/m² 1252  50.1 % 
Child characteristics     
Female sex  1354  47.3 % 
Duration of exclusive breastfeeding (mo) 1352  0.9 ± 1.1 
Gestational age (weeks of amenorrhea) 1354  39.2 ±1.7 
Birthweight (g) 1354  3267 ± 509 
Occurrence of diarrhea between 0-4 mo 1337  21.3 % 
Occurrence of regurgitations between 0-4 mo 1328  62.2 % 
Other variables 
       Recruitment center (% Poitiers) 1354  50.8 % 
Type of physician consulted between 0-4 mo, General practitioner 1350  28.4 % 
 524 
525 
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 526 
TABLE 2: Z-scores at birth and 4 months by type of formula predominantly used in the EDEN cohort study 
(n=1,239). 
  Type of formula-milk 
WHO Z-scores 
Regular   
(n=432) 
Partially 
hydrolyzed 
(n=165) 
Thickened 
(n=166) 
Pre-/ Probiotics 
(n=278) 
Others   
(n=198) 
Birth 
     Weight-for-age   0 .04 ± 0 .88
a
  0 .12 ± 0 .91 0 .002 ± 0 .94 -0 .01 ± 0 .89 -0 .07 ± 1 .01 
Length-for-age  0 .18 ± 0 .98  0 .22 ± 1 .08 0 .07 ± 1 .11  0 .12 ± 1 .00  0 .05 ± 1 .20 
Weight-for-length -0 .07 ± 1 .11 -0 .01 ± 1 .11 -0 .005 ± 1 .15 -0 .07 ± 1 .13 -0 .10 ± 1 .20 
4 months 
     Weight-for-age -0 .25 ± 0 .82 -0 .31 ± 0 .86 -0 .21 ± 0 .78 -0 .26 ± 0 .86 -0 .42 ± 0 .87 
Length-for-age -0 .10 ± 0 .90 -0 .03 ± 0 .96 -0 .12 ± 0 .91 -0 .09 ± 0 .92 -0 .18 ± 0 .97 
Weight-for-length -0 .20 ± 0 .88 -0 .34 ± 0 .95 -0 .11 ± 0 .78 -0 .21 ± 0 .85 -0 .34 ± 0 .85 
a 
: mean ± SD  
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TABLE 3: Adjusted Odds-Ratios (OR) of the relations between predominant type of formula used and parental and child characteristics, and type of physician 
consulted (n=1,354). 
  Type of formula-milk (Regular as reference, n=463))   
 
Partially hydrolyzed 
(n=176) 
Thickened     
(n=187) 
Pre-/probiotics 
(n=293) 
Others         
(n=235) Global p-value
a
 
 OR 95%CI OR 95%CI OR 95%CI OR 95%CI 
          Parental characteristics                  
Maternal Education (Ref: No degree) 
        
   0.10 
High school degree 1.26 0.68-2.36 1.33 0.80-2.19 1.38 0.88-2.17 1.07 0.65-1.77 
 2-year university degree  1.38 0.75-2.54 0.86 0.49-1.49 1.20 0.75-1.92 1.36 0.82-2.34 
 ≥ 3-year university degree 2.37 1.31-4.27 0.94 0.53-1.64 1.31 0.81-2.10 1.69 1.02-2.78 
 Monthly family income (Ref: 1501-2300 €) 
        
  0.54 
<1501 1.06 0.56-2.00 0.93 0.53-1.61 0.81 0.49-1.36 0.78 0.46-1.33 
 2301-3000 1.05 0.63-1.75 0.97 0.60-1.58 1.50 0.83-1.87 1.12 0.73-1.73 
 >3000  1.57 0.91-2.71 1.57 0.91-2.70 1.51 0.95-2.39 1.06 0.64-1.75 
 Parity (Ref: 1) 
        
<0.001 
2 0.64 0.40-0.98 1.65 1.11-2.46 1.28 0.91-1.80 1.13 0.78-1.65 
 ≥ 3  0.27 0.14-0.50 0.71 0.40-1.29 0.63 0.38-1.02 0.62 0.37-1.03 
 Mother returned to employment in the first 4 months (Ref: No) 0.85 0.57-1.28 1.49 1.01-2.22 1.17 0.84-1.64 0.83 0.57-1.19   0.05 
Family history of allergy (Ref: No) 2.11 1.44-3.08 1.49 1.04-2.14 1.19 0.87-1.61 1.32 0.95-1.83    0.002 
Country of birth (Ref: Both born in France) 
        
   0.19 
One of them born outside France  0.87 0.46-1.66 1.25 0.64-2.45 1.70 0.91-3.17 0.77 0.45-1.31 
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Child characteristics                   
Female sex (Ref: Male) 0.96 0.66-1.40 0.82 0.57-1.18 1.00 0.73-1.36 1.12 0.80-1.55    0.68 
Duration of exclusive breastfeeding (mo) 1.48 1.25-1.75 0.73 0.60-0.89 1.02 0.88-1.90 1.01 0.86-1.18 <0.001 
Gestational age (weeks of amenorrhea) 0.94 0.82-1.09 0.93 0.82-1.06 1.03 0.91-1.15 0.91 0.81-1.02    0.32 
Birthweight (g) 1.27 0.79-2.03 0.87 0.55-1.37 0.84 0.57-1.25 0.69 0.45-1.05    0.20 
Occurrence of diarrhea between birth and 4 mo (Ref: No) 0.74 0.46-1.20 0.66 0.43-1.02 0.73 0.50-1.08 0.94 0.63-1.39    0.25 
Occurrence of regurgitations between birth and 4 mo  (Ref: No) 0.99 0.68-1.45 2.68 1.80-3.98 1.74 1.27-2.39 1.48 1.06-2.08 <0.001 
Other variables                   
Recruitment center: Nancy (Ref: Poitiers) 0.58 0.39-0.86 0.89 0.61-1.30 0.86 0.62-1.18 0.92 0.65-1.30    0.10 
Type of physician consulted  between birth and 4 mo (Ref: GP
b
) 
       
   0.10 
Pediatrician 1.46 0.84-2.53 1.14 0.65-1.97 1.57 1.01-2.46 1.82 1.11-2.99 
 GP and pediatrician 1.22 0.74-1.99 1.41 0.89-2.23 1.16 0.77-1.73 1.73 1.11-2.67 
 Specialist with/no GP or pediatrician 1.95 1.13-3.36 1.71 1.01-2.89 1.71 1.09-2.69 1.98 1.20-3.27 
 a Multinomial logistic regression with regular formula as a reference group.   527 
b
 General practitioner. 528 
529 
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 530 
TABLE 4 : Linear regression models with weight-for-age, weight-for-length and length-for-age z-score change between birth and 4 months as 
dependent variables and covariates related to parents, child and type of physician consulted (n=1,239). 
 
Δ  WHO Z-scoresa 
 
Weight-for-age    Weight-for-length Length-for-age 
  Estimateb 95% CIc   Estimate 95% CI Estimate 95% CI 
Child characteristics               
Type of formula-milk (Ref: Regular) 
       Partially hydrolyzed  -0.07 -0.22, 0.07 
 
-0.19 -0.41, 0.04  0.08 -0.07, 0.24 
Thickened   0.05 -0.09, 0.19 
 
 0.03 -0.19, 0.25  0.07 -0.09, 0.22 
Enriched in pre- or probiotics   0.08 -0.04, 0.20 
 
 0.06 -0.12, 0.25  0.05 -0.08, 0.18 
Others  -0.04 -0.18, 0.09 
 
-0.09 -0.30, 0.12  0.01 -0.14, 0.15 
Duration of exclusive breastfeeding (mo) -0.08 -0.12, 0.04 
 
-0.04 -0.11, 0.03 -0.08 -0.12, -0.03 
Gestational age (weeks of amenorrhea) -0.21 -0.25, -0.17 
 
-0.12 -0.17, -0.07 -0.11 -0.15, -0.07 
Occurrence of diarrhea between birth and 4 mo (Ref: No) -0.01 -0.12, 0.10 
 
 0.04 -0.13, 0.21 -0.05 -0.17, 0.07 
Occurrence of regurgitations between birth and 4 mo (Ref: No)  0.01 -0.08, 0.10 
 
 0.08 -0.06, 0.22 -0.04 -0.14, 0.06 
Parental characteristics 
       Maternal BMI, kg/m² (Ref: Normal) 
       Thin  -0.08 -0.25, 0.09 -0.18 -0.45, 0.08 – – 
Overweight -0.08 -0.20, 0.04 
 
 0.02 -0.16, 0.21 – – 
Obese -0.25 -0.42,-0.09 
 
-0.10 -0.35, 0.16 – – 
Paternal BMI, kg/m² (Ref: Normal)  
     
– – 
Missing  0.21 0.03, 0.39 
 
 0.12 -0.16, 0.39 – – 
Overweight   0.11 0.01, 0.20 
 
 0.12 -0.03, 0.27 – – 
Obese   0.25 0.08, 0.42 
 
 0.47 0.21, 0.74 – – 
Other variables 
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Type of physician consulted  between birth and 4 mo (Ref: GP
d
) 
       Pediatrician  -0.12 -0.25, 0.01 
 
-0.31 -0.51, -0.11  0.01 -0.04, 0.24 
GP and pediatrician -0.03 -0.15, 0.09 
 
-0.12 -0.30, 0.06  0.01 -0.12, 0.13 
Specialist with/no GP or pediatrician  -0.01 -0.15, 0.12 
 
-0.06 -0.27, 0.14 -0.01 -0.16, 0.13 
a
 Change in z-score between birth and 4 months. 531 
b
 Adjusted for recruitment center, maternal education, monthly family income, mother's return to employment, infant's sex, parental heights (for the analyses on length-for-532 
age z-score) average z-score between 0 and 4 months. 533 
c 
Confidence interval 534 
d 
General practitioner 535 
 536 
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